Association between Modified Cardiometabolic Index and rheumatoid arthritis: the mediating role of phenotypic age acceleration
摘要
Modified Cardiometabolic Index (MCMI) is a novel metabolic assessment metric integrating waist-to-height ratio (WHtR), lipid, and fasting plasma glucose (FPG). Rheumatoid arthritis (RA), as an autoimmune disease, is closely linked to metabolic status, yet the relation of MCMI to RA remains unclear. Phenotypic age acceleration (PAA), reflecting biological aging, possibly mediates the relation of MCMI to RA. Our study aimed to elucidate the relation of MCMI to RA and assess the mediating effect of PAA.
Methods1999–2010 and 2015–2020 National Health and Nutrition Examination Survey (NHANES) data on 10,564 adults were analyzed. RA status was determined via questionnaire. MCMI was calculated based on WHtR, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and FPG. PAA was derived as the residual of phenotypic age (PA) regressed on chronological age. The association of MCMI with RA was examined via weighted logistic regression (WLR), restricted cubic splines (RCS) assessed potential nonlinearity, and mediation analysis examined the effect of PAA.
ResultsIn multivariable-adjusted models, every one-unit rise in MCMI was related to a 45.1% higher RA prevalence (OR = 1.451, 95% CI: 1.250–1.685). MCMI was split into tertiles. The highest tertile (T3) displayed a significantly higher RA prevalence than the lowest tertile (T1) (OR = 1.879, 95% CI: 1.379–2.559). RCS analysis indicated a linear relation of MCMI to RA (P for nonlinear = 0.331). PAA accounted for 17.446% of the relation of MCMI to RA in mediation analysis (P < 0.001).
ConclusionMCMI is positively associated with RA risk, with PAA partially mediating this relationship. These findings suggest that metabolic dysregulation may influence RA development through accelerated biological aging, providing a novel perspective for early prevention and metabolic interventions in RA.